Assessing Soleno Therapeutics (SLNO) Valuation After JCEM VYKAT XR Data And FDA Approval

Why the latest JCEM publication matters for Soleno Therapeutics (SLNO) Soleno Therapeutics (SLNO) is back in focus after a ...
The Manila Times

Soleno Therapeutics Announces Publication of Results from Pivotal Study of VYKAT™ XR in the Journal of Clinical Endocrinology and Metabolism

Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the ...

Soleno Therapeutics (SLNO) Among Stocks That Will Bounce Back According to Analysts

Soleno Therapeutics, Inc. (NASDAQ:SLNO) is one of the 12 Stocks that Will Bounce Back According to Wall Street Analysts. On ...
Healio

Withdrawal from oral therapy tied to worsened hyperphagia in Prader-Willi syndrome

Children and adults with Prader-Willi syndrome who previously received once-daily diazoxide choline extended-release tablets ...
Zacks.com on MSN

Zacks Industry Outlook Highlights Soleno Therapeutics, Nektar Therapeutics, Rigel Pharmaceuticals, Ironwood Pharmaceuticals and Marker Therapeutics

Detailed price information for Rigel Pharmaceuticals (RIGL-Q) from The Globe and Mail including charting and trades.
TipRanks on MSN

Soleno Therapeutics announces publication of VYKAT XR study results in JCEM

Soleno Therapeutics (SLNO) announced a publication in the peer-reviewed Journal of Clinical Endocrinology and Metabolism. The paper, titled, ...
TMCnet

Soleno Therapeutics, Inc. INVESTIGATION: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud on behalf of Investors (SLNO)

The law firm of Kirby McInerney LLP is investigating potential claims against Soleno Therapeutics, Inc. ("Soleno" or the "Company") (NASDAQ:SLNO). The investigation concerns whether the Company and/or ...
abc27

Johnson Fistel Begins Investigation on Behalf of Soleno Therapeutics, Inc. (SLNO) Shareholders Who Have Incurred Losses

SAN DIEGO, Dec. 15, 2025 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, PLLP is investigating whether Soleno Therapeutics, Inc. (NASDAQ: SLNO) or certain of its officers and directors ...